Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA

ARDEA BIOSCIENCES, INC. (RDEA)
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Ardea Biosciences, Inc. : Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Law Offices of Howard G. Smith

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 05:10pm CEST

Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. ("Ardea" or the "Company") (NASDAQ: RDEA) related to the proposed acquisition of the Company by AstraZeneca. The transaction is valued at approximately $1.26 billion or $32 per share.

This investigation concerns whether the Board of Directors of Ardea breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. The Company has seen substantial recent growth. Further, at least one analyst has set a target price for the Company's stock at $40.00 per share.

If you are a shareholder of Ardea, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [email protected], or visit our website at http://www.howardsmithlaw.com.

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
(215) 638-4847
Toll Free, (888) 638-4847
[email protected]
http://www.howardsmithlaw.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ARDEA BIOSCIENCES, INC.
2012AstraZeneca hungry to refill medicine cabinet
RE
2012AstraZeneca Completes Acquisition of Ardea Biosciences
DJ
2012GSK goes hostile with $2.6 billion Human Genome offer
RE
2012Biotech targets fight back as Big Pharma circles
RE
2012ARDEA BIOSCIENCES, INC. : Securities Lawyers at Goldfarb LLP Seeking More Money,..
PR
2012Warner Chilcott to explore sale of company
RE
2012ARDEA BIOSCIENCES, INC. : Law Office of Brodsky & Smith, LLC Announces Investiga..
BU
2012Pharma M&A Surge Spurred By Necessity And Opportunity
DJ
2012AstraZeneca CEO quits as drug sales tumble
RE
2012Watson to buy Actavis for at least $5.6 billion
RE
More news
Chart ARDEA BIOSCIENCES, INC.
Duration : Period :
Ardea Biosciences, Inc. Technical Analysis Chart | RDEA | US03969P1075 | 4-Traders
Income Statement Evolution
Sector and Competitors
1st jan.Capitalization (M$)
ARDEA BIOSCIENCES, INC.0
GILEAD SCIENCES3.31%96 094
VERTEX PHARMACEUTICALS5.89%40 153
REGENERON PHARMACEUTICALS-15.95%33 844
GENMAB23.13%12 797
BEIGENE LTD (ADR)71.91%8 998